Antiresorptive and anabolic agents in the prevention and reversal of bone fragility

E Seeman, TJ Martin - Nature Reviews Rheumatology, 2019 - nature.com
Bone volume, microstructure and its material composition are maintained by bone
remodelling, a cellular activity carried out by bone multicellular units (BMUs). BMUs are …

Strontium modified calcium phosphate cements–approaches towards targeted stimulation of bone turnover

M Schumacher, M Gelinsky - Journal of Materials Chemistry B, 2015 - pubs.rsc.org
Making use of the potential of calcium phosphates to host a variety of ions in their crystal
lattice, ion substitution of calcium phosphate bone cements has become the subject of …

Anti-osteoporosis therapy and fracture healing

S Larsson, NL Fazzalari - Archives of orthopaedic and trauma surgery, 2014 - Springer
Background A number of medications are approved for treatment of osteoporosis. As mode
of action usually is anti-catabolic/anti-resorptive or anabolic, it is of interest to know whether …

Pharmacological therapies for the management of inflammatory bone resorption in periodontal disease: a review of preclinical studies

ALR Pavanelli, BS De Menezes… - BioMed Research …, 2022 - Wiley Online Library
Periodontitis, a highly prevalent multicausal chronic inflammatory and destructive disease,
develops as a result of complex host‐parasite interactions. Dysbiotic bacterial biofilm in …

Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice

AR Irizarry, G Yan, Q Zeng, J Lucchesi, MJ Hamang… - PloS one, 2017 - journals.plos.org
There has been growing recognition of the essential roles of citrate in biomechanical
properties of mineralized tissues, including teeth and bone. However, the sources of citrate …

Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment

JI Felice, L Schurman, AD McCarthy… - Diabetes research and …, 2017 - Elsevier
Aims Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this
study we evaluated the effects of a fructose-induced MS, and/or an oral treatment with …

Abaloparatide is an anabolic, but does it spare resorption?

TJ Martin, E Seeman - Journal of Bone and Mineral Research, 2017 - academic.oup.com
Longevity is increasing the burden of fractures. Although antiresorptive therapy slows
remodeling, it does not prevent or repair microstructural deterioration. The challenge is to …

Additive effect of PTH (1–34) and zoledronate in the prevention of disuse osteopenia in rats

JB Vegger, ES Nielsen, A Brüel, JS Thomsen - Bone, 2014 - Elsevier
Immobilization is known to cause a rapid bone loss due to increased osteoclastic bone
resorption and decreased osteoblastic bone formation. Zoledronate (Zln) is a potent anti …

Reduced bone modeling and unbalanced bone remodeling: targets for antiresorptive and anabolic therapy

SK Ramchand, E Seeman - Bone Regulators and Osteoporosis Therapy, 2020 - Springer
Bone loss during advancing age is the net result of reduced modeling-based bone formation
upon the outer (periosteal) envelope and unbalanced remodeling by basic multicellular …

Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis

DB Hoffmann, S Sehmisch, AM Hofmann… - Journal of bone and …, 2017 - Springer
We investigated the combinatorial effects of whole-body vertical vibration (WBVV) with the
primarily osteoanabolic parathyroid hormone (PTH) and the mainly antiresorptive strontium …